DAS (n = 205) | Usual care (n = 179) | Total (n = 384) | ||||
---|---|---|---|---|---|---|
The percentages do not add up to 100, because of combination therapy. DMARDs used by single patients were summed up as “other DMARDs.” | ||||||
DAS, disease activity score; DMARD, disease modifying antirheumatic drug; NSAID, non-steroidal anti-inflammatory drug. | ||||||
Methotrexate | 94 (46%) | 93 (52%) | 187 (49%) | |||
Sulfasalazine | 54 (26%) | 47 (26%) | 101 (26%) | |||
Hydroxychloroquine | 31 (15%) | 17 (10%) | 48 (13%) | |||
Aurothioglucose | 16 (8%) | 8 (5%) | 24 (6%) | |||
Ciclosporin | 6 (3%) | 3 (2%) | 9 (2%) | |||
Azathioprine | 7 (3%) | 1 (1%) | 8 (2%) | |||
Other DMARDs | 3 (1%) | 5 (3%) | 8 (2%) | |||
Prednisone | 44 (21%) | 25 (14%) | 69 (18%) | |||
NSAIDs | 172 (84%) | 133 (74%) | 305 (79%) |